Biotech Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Week


We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Genzyme Corp.

First quarter yields 30% increase in revenues

Revenues for the quarter rose 30% to $314.0 million, compared to $242.1 million for the same period last year.

Reported net income allocated to Genzyme General stock was $61.9 million, or $0.28 per diluted share, approximately double net income of $30.7 million, or $0.14 per diluted share, recorded for the first quarter a year ago. Excluding amortization of $9.7 million, or $0.03 per share, net income increased 49% to $68.0 million, or $0.31 per diluted share, compared with $45.5 million, or $0.21 per diluted share, prior to amortization and special items...

• View Other Issues of Biotech Week
  
• View Other NewsRx Publications